CARBAMAZEPINE
- Product NDC
- 67296-1637
- 11-digit product format
- 672961637
- Labeler code
- 67296
- Product ID
- 67296-1637_b8d08b7b-cbff-9efd-e053-2995a90a89e7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA075948
- Marketing category
- ANDA
- Marketing start
- 2019-01-01
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1637-2 | CARBAMAZEPINE | 20 in 1 BOTTLE | TABLET | 20 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1637 | CARBAMAZEPINE TABLET [REDPHARM DRUG, INC.] | 2 | Legacy NDC, 1 package rows | 20210114_88dd818c-80b5-a85c-e053-2a95a90aa84d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1637-2 | 67296163702 | 20 TABLET in 1 BOTTLE (67296-1637-2) | 20 tablet | 2019-01-01 | 0000-00-00 | No | No | Current |